Plain-English translation of NCT07182942 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 4 โ The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing a medication called , which works by absorbing harmful waste products that build up when your kidneys aren't working well. The researchers want to see if works better on its own, combined with (beneficial bacteria), or if alone might help. They'll measure changes in your gut bacteria, waste levels in your blood, and kidney function over time.
When kidneys don't work properly, toxic waste builds up in your body and can cause serious problems. Recent research suggests that your gut health plays a key role in how well kidney disease treatments work, so this trial is exploring whether improving your gut bacteria alongside this medication might slow kidney disease progression more effectively.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join, you'll be randomly assigned to receive either alone, alone, or both together for a set period. You'll visit the clinic for regular check-ups where researchers will collect blood samples to measure kidney function and waste levels, and may collect stool samples to study your gut bacteria. The trial uses advanced tests to track how the treatment affects your gut health, inflammation, and kidney disease progression.
AI-generated summary from trial data ยท Jun 9, 2026 ยท Not medical advice
China